Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

Xth Eurasian Hematology-Oncology Congress
M

What is the Role and Best Sequencing of the New Generation Hormonal Agents in the Treatment of Castration Sensitive Metastatic Prostate Cancer and When Not to Use Hormonal Agents?

By Xth Eurasian Hematology-Oncology Congress FEATURING Mustafa Erman
By Xth Eurasian Hematology-Oncology Congress FEATURING Mustafa Erman
47 views
December 4, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip
Genitourinary
18:54

Stage I Testicular Cancer: Who Needs Treatment and Which One?

Xth Eurasian Hematology-Oncology Congress

O. Dizdar

204 views
14:30

How to Treat Cisplatin-Ineligible Metastatic Bladder Cancer: CPi Str…

Xth Eurasian Hematology-Oncology Congress

A. Karaoglu

59 views
06:15

How to Treat Cisplatin-Ineligible Metastatic Bladder Cancer: Non-Cis…

Xth Eurasian Hematology-Oncology Congress

A. Karaoglu

48 views
16:18

What is the Role and Best Sequencing of the New Generation Hormonal …

Xth Eurasian Hematology-Oncology Congress

M. Erman

40 views
17:28

What is the Role and Best Sequencing of the New Generation Hormonal …

Xth Eurasian Hematology-Oncology Congress

M. Erman

47 views
26:23

Perioperative Systemic Therapy for Localized Renal Cell Carcinoma: T…

Xth Eurasian Hematology-Oncology Congress

C. Arslan

61 views